Anti-SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain Antibody, Clone Covi-2 (Blocking/Recombinant)

Human monoclonal IgG1 antibody against SARS-CoV-2 (2019-nCoV) S protein (HEK293-expressed recombinant)
Anti-SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain Antibody, Clone Covi-2 (Blocking/Recombinant)

Human monoclonal IgG1 antibody against SARS-CoV-2 (2019-nCoV) S protein (HEK293-expressed recombinant)

100 µg
Catalog # 100-0584
452 USD

Overview

The Anti-SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain Antibody, Clone Covi-2 (Blocking/Recombinant antibody reacts with Spike Protein S1 receptor binding domain (RBD) expressed by SARS-associated coronavirus 2 (SARS-CoV-2/2019-nCoV).

The Spike (S) protein is a type I transmembrane glycoprotein present on the surface of coronaviruses (CoV). Entry of CoV into host cells is mediated by the S protein, where it interacts with the cell-surface receptor angiotensin-converting enzyme 2 (ACE2). In humans, ACE2 is expressed in several organs and tissues, including intestinal and respiratory epithelium.

The S protein has two subunits, S1 and S2, where S1 primarily consists of the 193 amino acid long RBD and the N-terminal domain (NTD). The S2 domain is responsible for membrane fusion. During CoV infection, the S protein is cleaved into the N-terminal S1 subunit and C-terminal S2 subunit by host proteases, transforming its conformation from the pre-fusion to the post-fusion state. The S protein has been shown to play a key role in the induction of neutralizing antibody and T cell responses, which may lead to protective immunity. The RBD binds to ACE2, while the function of the NTD is not well understood. The Covi-2 antibody blocks the interaction of the S1 subunit with the ACE2 receptor and binds to a different epitope than the Covi-1 antibody.
Subtype
Primary Antibodies
Target Antigen
SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain
Alternative Names
SARS-CoV-2 Spike Protein, SARS-CoV-2 S Protein, SARS-CoV-2 S1 Protein
Conjugation
Unconjugated
Host Species
Human
Application
ELISA, Neutralization and Blocking, Western Blotting
Area of Interest
Immunology, Infectious Diseases, Respiratory Research
Clone
Covi-2
Gene ID
N/A (Uniprot: P0DTC2)
Isotype
IgG1

Scientific Resources

Product Documentation

Document Type Product Name Catalog # Lot # Language
Document Type
Product Information Sheet
Product Name
Anti-SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain Antibody, Clone Covi-2 (Blocking/Recombinant)
Catalog #
100-0584
Lot #
All
Language
English

Educational Materials (8)

Brochure
Reliable Antibodies for Your Research
Brochure
Tools For Your Immunology Research
Wallchart
SnapShot: COVID-19
Video
Collaborating to Accelerate COVID-19 Research
3:36
Collaborating to Accelerate COVID-19 Research
Webinar
SARS-CoV-2 Viral Diversity: Causes, Consequences, and Opportunities
45:33
SARS-CoV-2 Viral Diversity: Causes, Consequences, and Opportunities
Webinar
HUB & STEMCELL Organoids as Models of Infectious Disease Mini-Symposium
1:10:09
HUB & STEMCELL Organoids as Models of Infectious Disease Mini-Symposium
Webinar
Studying Respiratory Viruses with ALI Cultures
6:56
Studying Respiratory Viruses with ALI Cultures
Webinar
Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System
1:00:11
Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System

Data and Publications

Data

Data figures showing that the binding between recombinant human ACE2 to the Spike protein S1 RBD is inhibited in the presence of increasing concentration of Covi-2 antibody.

Figure 1. Inhibitory Effect of Covi-2 Antibody on Spike Protein Receptor-Binding Domain and ACE2 Interaction

ELISA binding assay shows that at high concentrations, Anti-SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain Antibody, Clone Covi-2 (Blocking/Recombinant) (orange line) blocks biotinylated recombinant human ACE2 from binding to an ELISA plate coated with recombinant SARS-CoV-2 Spike protein S1 RBD, in comparison to a negative control antibody (blue line). The binding of biotinylated recombinant human ACE2 to the Spike protein S1 RBD was detected using streptavidin horseradish peroxidase (HRP). The results were plotted as (A) absorbance (450 nm) or (B) binding percentage.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.